Allspring Global Investments’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.24M Sell
173,444
-2,775
-2% -$87.5K 0.01% 840
2026
Q1
$4.93M Buy
176,219
+155,494
+750% +$5.1M 0.01% 865
2025
Q4
$776K Buy
20,725
+1,811
+10% +$59.5K ﹤0.01% 1235
2025
Q3
$521K Sell
18,914
-187
-1% -$6.44K ﹤0.01% 1340
2025
Q2
$604K Sell
19,101
-1,120
-6% -$36K ﹤0.01% 1289
2025
Q1
$671K Buy
20,221
+6,915
+52% +$248K ﹤0.01% 1368
2024
Q4
$458K Sell
13,306
-17,803
-57% -$612K ﹤0.01% 1479
2024
Q3
$1.24M Sell
31,109
-1,193
-4% -$41.9K ﹤0.01% 1278
2024
Q2
$975K Sell
32,302
-2,970
-8% -$89.3K ﹤0.01% 1341
2024
Q1
$1.18M Buy
35,272
+397
+1% +$12.7K ﹤0.01% 1322
2023
Q4
$1.13M Sell
34,875
-15,256
-30% -$426K ﹤0.01% 1316
2023
Q3
$1.64M Buy
50,131
+804
+2% +$27.9K ﹤0.01% 1242
2023
Q2
$1.74M Buy
49,327
+13,225
+37% +$457K ﹤0.01% 1281
2023
Q1
$1.18M Sell
36,102
-185,921
-84% -$8.47M ﹤0.01% 1385
2022
Q4
$12.2M Buy
222,023
+98,246
+79% +$5.4M 0.02% 727
2022
Q3
$5.48M Buy
123,777
+121,174
+4,655% +$5.91M 0.01% 951
2022
Q2
$126K Sell
2,603
-9,531
-79% -$429K ﹤0.01% 1978
2022
Q1
$590K Buy
12,134
+2,249
+23% +$91.7K ﹤0.01% 2151
2021
Q4
$421K Buy
+9,885
New +$394K ﹤0.01% 2366

Other funds holding HRMY

Allspring Global Investments's HRMY Position: Q2 2026 in Review

Allspring Global Investments reduced its Harmony Biosciences (HRMY) stake by 1.6% in Q2 2026, selling an estimated $87.5K and leaving 173,444 shares worth $6.24M. The position accounts for 0.01% of the portfolio, ranked #840.

Allspring Global Investments first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $12.2M in Q4 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Allspring Global Investments held 173,444 shares of Harmony Biosciences worth $6.24M as of Q2 2026.
  • Allspring Global Investments sold 2,775 Harmony Biosciences shares in Q2 2026, an estimated $87.5K.
  • Harmony Biosciences made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #840 holding.
  • Allspring Global Investments first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Harmony Biosciences position peaked at $12.2M in Q4 2022.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.